Last updated: 11/07/2018 11:32:16
PGx: Exploratory Analysis of Whole Bacterial Genome DNA Sequences of Escherichia coli Isolates from Two Patients Enrolled in the LRS114688 PhII cUTI Clinical Study
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: PGx: Exploratory Analysis of Whole Bacterial Genome DNA Sequences of Escherichia coli Isolates from Two Patients Enrolled in the LRS114688 PhII cUTI Clinical Study
Trial description: PGx: Exploratory Analysis of Whole Bacterial Genome DNA Sequences of Escherichia coli Isolates from Two Patients Enrolled in the LRS114688 PhII cUTI Clinical Study
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
O’Dwyer K, Spivak A, Ingraham K, Min S, Holmes D, Jakielaszek C, Rittenhouse S, Kwan A, George L, Sathe G, Thomas E, Van Horn S, Miller L, Twynholm M, Tomayko J, Dalessandro M, Caltabiano M, Scangarella-Oman N, Brown JR.Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections.Antimicrob Agents Chemother.2015;59(1):289-98doi: 10.1128/AAC.03774-14
Medical condition
Infections, Bacterial
Product
epetraborole
Collaborators
Not applicable
Study date(s)
March 2012 to August 2012
Type
Not applicable
Phase
Not applicable
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2012-10-08
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website